Allelica, a leader in genomic risk assessment for common diseases, announced today that polygenic risk scores (PRS) have been recognized as a risk-enhancing factor in the 2026 American College of ...
Biologically enriched MetPRS has the potential to add an extra layer of information to metabolic disease prediction and management approaches.
The PROMISE minimal risk score identifies patients with recent-onset stable chest pain who can safely avoid extra testing and ...
Transcriptomic and clinical data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus were used to construct a 12-gene ARG-based prognostic signature through LASSO and Cox regression ...
Posttransplant cyclophosphamide–containing prophylaxis correlated with lower aGVHD risk than tacrolimus/methotrexate, and ATG ...
The Morningstar Portfolio Risk Score (MPRS) is a single number that represents the current, forward-looking risk of a given portfolio or investment. It is intended to help any user quickly assess the ...